Labshake search
Citations for Stemcell Technologies :
1 - 19 of 19 citations for MERS Coronavirus Spike Glycoprotein S1 His tag E. coli since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... 0.1 µM Compound-E (StemCell Technologies), 2ng/mL BDNF ...
-
bioRxiv - Neuroscience 2023Quote: ... Compound E (0.1 μM; STEMCELL Technologies), db-cAMP (0.5 mM ...
-
bioRxiv - Neuroscience 2023Quote: ... and Compound E (73952, StemCell Technologies) using the protocol 26 ...
-
bioRxiv - Cell Biology 2022Quote: ... Compound E (0.1 μM; STEMCELL Technologies; 73954), db-cAMP (0.5 mM ...
-
bioRxiv - Neuroscience 2022Quote: ... 0.2 µM Compound E (Stem Cell Technologies), 1 µg/mL Laminin (R&D ...
-
bioRxiv - Neuroscience 2022Quote: ... supplemented with 1% N2 supplement and 2% NeuroCult S1 supplement (STEMCELL Technologies, Vancouver, BC). After one day media was removed and replaced with a thin layer of phosphate buffered saline ...
-
bioRxiv - Neuroscience 2022Quote: ... and 0.2 µM Compound E (Stem Cell Technologies). On day 3 ...
-
bioRxiv - Neuroscience 2021Quote: ... 2mM Dorsomorphin (Miltenyi) and 0.1mM Compound E (StemCell Technologies). Medium was changed daily for 2 days ...
-
bioRxiv - Neuroscience 2024Quote: ... 0.1 µM Compound E (CpdE, StemCell Technologies; Cat#73954), and 10 ng/ml insulin-like growth factor-1 (IGF-1 ...
-
bioRxiv - Immunology 2021Quote: ... Hybridomas were thawed and expanded in ClonaCell-HY Growth Medium E (Stem Cell Technologies) up to a volume of 300ml ...
-
bioRxiv - Immunology 2019Quote: ... before centrifugation and resuspension in Clonacell-HY Medium E (StemCell Technologies, Vancouver, BC, Canada) supplemented with HAT (Sigma-Aldrich ...
-
bioRxiv - Immunology 2021Quote: The 7D9 hybridoma line was cultured in ClonaCell™-HY Medium E (STEMCELL Technologies) prior to antibody production ...
-
bioRxiv - Immunology 2021Quote: ... The selected cloned cell lines secreting mAb H5.28 or H5.31 were grown initially in hybridoma growth medium (ClonaCell-HY medium E from STEMCELL Technologies). Prior to antibody expression and purification ...
-
bioRxiv - Immunology 2020Quote: ... and cells from wells with reactive supernatants were expanded to 48-well plates for 1 week in 0.5 mL of StemCell medium E (StemCell Technologies), before being screened again by ELISA ...
-
bioRxiv - Immunology 2022Quote: ... and cells from wells with reactive supernatants were expanded to 48-well plates for 1 week in 0.5 mL of StemCell medium E (StemCell Technologies), before being screened again by ELISA ...
-
bioRxiv - Neuroscience 2019Quote: ... media was supplemented with Y27632, Laminin (2.5 µg per 1ml of media, Thermo-Fisher) and 0.1µM Compound-E (Stem Cell Technologies, Grenoble, France) during the first 3 days after plating in Poly-L-Lysine (Sigma ...
-
bioRxiv - Immunology 2021Quote: ... CD34+ umbilical cord and CD34+ hematopoietic stem/progenitor cell (Ethics Committee Salzburg approval 415-E/1776/4-2014) were isolated using density gradient centrifugation (Lymphoprep; Stemcell Technologies). Primary human cells ...
-
bioRxiv - Immunology 2019Quote: ... A total of 649 IgGpos/OVApos hybridoma cells were individually deposited into 96-well plates containing Medium E (StemCell Technologies, Vancouver, BC, Canada). Supernatants were screened by ELISA against OVA seven days after sorting ...
-
bioRxiv - Neuroscience 2023Quote: ... On day 3 cells were changed into a 50/50 ratio of fibroblast media and TeSR™ E-7™ Reprogramming Media (STEMCELL Technologies), and on day 5 were changed into 100% E-7™ Reprogramming Media ...